| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2023 | AKBA Akebia Therapeutics, Inc. | Hadas Nicole R.60 | SVP, Chief Legal Officer | Sell | 6,677 | $0.81 | $5,429.74 | -2.2% | +17.5% | +101.1% | |
| Feb 27, 2023 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 16,000 | $249.20 | $3,987,273.95 | -38.8% | -16.9% | -8.2% | |
| Feb 27, 2023 | PLSH Panacea Life Sciences Holdings, Inc. | Buttorff Leslie | CEO | Buy | 4,000 | $0.18 | $725.00 | +0.2% | - | - | |
| Feb 24, 2023 | AMLX Amylyx Pharmaceuticals, Inc. | Mazzariello Gina53 | Chief Legal Officer | Sell | 3,586 | $34.49 | $123,671.82 | -8.7% | -23.8% | -48.9% | |
| Feb 24, 2023 | VRNO Verano Holdings Corp. | Smullen Richard Michael | Director | Sell | 17,900 | $2.99 | $53,495.70 | -0.2% | - | - | |
| Feb 23, 2023 | NBIX Neurocrine Biosciences Inc | Neurocrine Biosciences Inc | 10% Owner | Buy | 4,395,588 | $8.88 | $39,032,821.44 | +105.2% | -9.1% | +31.7% | |
| Feb 23, 2023 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 16,000 | $247.64 | $3,962,301.88 | -18.4% | -13.8% | -8.6% | |
| Feb 23, 2023 | AMLX Amylyx Pharmaceuticals, Inc. | Morningside Venture Investments Ltd93 | 10% Owner | Sell | 100,000 | $35.78 | $3,578,102.71 | -0.3% | -24.1% | -50.1% | |
| Feb 22, 2023 | AMLX Amylyx Pharmaceuticals, Inc. | Morningside Venture Investments Ltd93 | 10% Owner | Sell | 50,000 | $34.73 | $1,736,351.68 | -0.3% | -24.2% | -48.7% | |
| Feb 22, 2023 | DERM Journey Medical Corp | Benesch Joseph | Interim CFO | Sell | 2,768 | $1.97 | $5,452.96 | -4.0% | -35.8% | +94.3% | |
| Feb 21, 2023 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 16,000 | $254.74 | $4,075,843.06 | -26.0% | -14.4% | -14.1% | |
| Feb 21, 2023 | VRNO Verano Holdings Corp. | Smullen Richard Michael | Director | Sell | 27,700 | $3.07 | $85,128.90 | -0.5% | - | - | |
| Feb 16, 2023 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 6,000 | $249.15 | $1,494,921.52 | -3.1% | -14.0% | -14.6% | |
| Feb 16, 2023 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 16,000 | $251.78 | $4,028,545.98 | -36.0% | -14.0% | -14.6% | |
| Feb 16, 2023 | VRNO Verano Holdings Corp. | Smullen Richard Michael | Director | Sell | 55,900 | $3.10 | $173,159.10 | -1.0% | - | - | |
| Feb 15, 2023 | ETST Earth Science Tech, Inc. | Saumat Giorgio R. | CEO | Buy | 10,000 | $0.05 | $450.00 | - | - | - | |
| Feb 15, 2023 | MRK Merck & Co., Inc. | Romanelli Joseph57 | President, Human Health Int?l | Sell | 5,000 | $108.22 | $541,100.50 | -19.8% | +8.5% | +20.8% | |
| Feb 15, 2023 | HIMS Hims & Hers Health, Inc. | Becklund Irene | Pao | Sell | 9,625 | $10.00 | $96,250.00 | -46.1% | +4.5% | +0.2% | |
| Feb 15, 2023 | LNTH Lantheus Holdings, Inc. | Sabens Andrea47 | Chief Accounting Officer | Sell | 386 | $57.52 | $22,202.72 | -0.6% | +62.3% | -3.8% | |
| Feb 15, 2023 | HIMS Hims & Hers Health, Inc. | Boughton Soleil | Chief Legal Officer | Sell | 67,000 | $9.99 | $669,570.00 | -14.2% | +4.5% | +0.2% | |
| Feb 14, 2023 | ZTS Zoetis Inc. | Lagano Roxanne70 | Executive Vice President | Sell | 13,010 | $175.00 | $2,276,750.00 | -33.0% | +7.0% | +7.1% | |
| Feb 14, 2023 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 16,000 | $254.66 | $4,074,492.07 | -44.0% | -15.3% | -15.3% | |
| Feb 14, 2023 | VRNO Verano Holdings Corp. | Smullen Richard Michael | Director | Sell | 73,885 | $2.98 | $220,487.96 | -1.3% | - | - | |
| Feb 13, 2023 | MRK Merck & Co., Inc. | Mizell Steven52 | EVP, Chief Hr Officer | Sell | 1,815 | $109.10 | $198,017.04 | -5.2% | +7.0% | +17.7% | |
| Feb 13, 2023 | COLL Collegium Pharmaceutical, Inc | Ciaffoni Joseph | President And CEO | Sell | 11,250 | $26.88 | $302,400.00 | -2.7% | -12.8% | +19.4% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.